Emerging viral diseases can substantially threaten national and global public health. Central
to our ability to successfully tackle these diseases is the need to quickly detect the causative …

Dengue is one of the highest and rapidly spreading vector-borne viral diseases with high
mortality rates. The infection causes acute febrile illness, a major public health concern in …

Monkeypox virus (MPXV) is a budding public health threat worldwide, and there lacks a
personalized drug availability to treat MPXV infections. Tecovirimat, an antiviral drug against …

Pirin (PIR) protein is highly conserved in both prokaryotic and eukaryotic organisms.
Recently, it has been identified that PIR positively regulates breast cancer cell proliferation …

The emergence of SARS-CoV-2 variants diminished the efficacy of current antiviral drugs
and vaccines. Hence, identifying highly conserved sequences and potentially druggable …

Colorectal cancer is considered one of the leading causes of death that is linked with the
Kirsten Rat Sarcoma (KRAS) harboring codons 13 and 61 mutations. The objective for this …

Neutralizing antibodies (NAbs) are naturally produced by our immune system to combat viral
infections. Clinically, neutralizing antibodies with potent efficacy and high specificity have …

The human KRAS (Kirsten rat sarcoma) is an oncogene, involved in the regulation of cell
growth and division. The mutations in the KRAS gene have the potential to cause normal …

The global pandemic caused by a single-stranded RNA (ssRNA) virus known as the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still at its peak, with new cases …

The human herpes simplex virus type 1 (HSV‐1) is an extremely rampant human pathogen,
and its infection could cause life‐long diseases, including the central nervous system …